Abstract:Adenosine kinase (ADK) deficiency in human patients (OMIM:614300) disrupts the methionine cycle and triggers hypermethioninemia, hepatic encephalopathy, cognitive impairment, and seizures. To identify whether this neurological phenotype is intrinsically based on ADK deficiency in the brain or if it is secondary to liver dysfunction, we generated a mouse model with a brain-wide deletion of ADK by introducing a Nestin-Cre transgene into a line of conditional ADK deficient Adkfl/fl mice. These AdkΔbrain mice developed a progressive stress-induced seizure phenotype associated with spontaneous convulsive seizures and profound deficits in hippocampus-dependent learning and memory. Pharmacological, biochemical, and electrophysiological studies suggest enhanced adenosine levels around synapses resulting in an enhanced adenosine A1 receptor (A1R)-dependent protective tone despite lower expression levels of the receptor. Theta-burst-induced LTP was enhanced in the mutants and this was dependent on adenosine A2A receptor (A2AR) and tropomyosin-related kinase B signaling, suggesting increased activation of these receptors in synaptic plasticity phenomena. Accordingly, reducing adenosine A2A receptor activity in AdkΔbrain mice restored normal associative learning and contextual memory and attenuated seizure risk. We conclude that ADK deficiency in the brain triggers neuronal adaptation processes that lead to dysregulated synaptic plasticity, cognitive deficits, and increased seizure risk. Therefore, ADK mutations have an intrinsic effect on brain physiology and may present a genetic risk factor for the development of seizures and learning impairments. Furthermore, our data show that blocking A2AR activity therapeutically can attenuate neurological symptoms in ADK deficiency. SIGNIFICANCE STATEMENT A novel human genetic condition (OMIM #614300) that is based on mutations in the adenosine kinase (Adk) gene has been discovered recently. Affected patients develop hepatic encephalopathy, seizures, and severe cognitive impairment. To model and understand the neurological phenotype of the human mutation, we generated a new conditional knock-out mouse with a brain-specific deletion of Adk (AdkΔbrain). Similar to ADK-deficient patients, AdkΔbrain mice develop seizures and cognitive deficits. We identified increased basal synaptic transmission and enhanced adenosine A2A receptor (A2AR)-dependent synaptic plasticity as the underlying mechanisms that govern these phenotypes. Our data show that neurological phenotypes in ADK-deficient patients are intrinsic to ADK deficiency in the brain and that blocking A2AR activity therapeutically can attenuate neurological symptoms in ADK deficiency.

Adenylate Kinase: A Ubiquitous Enzyme Correlated with Medical Conditions

Adenylate Kinase Isoform Network: A Major Hub in Cell Energetics and Metabolic Signaling

Adenylate Kinase and Metabolic Signaling in Cancer Cells

Adenylate kinase AK2 isoform integral in embryo and adult heart homeostasis

Adenylate kinase 1 gene deletion disrupts muscle energetic economy despite metabolic rearrangement

Impacts of Mutations on Dynamic Allostery of Adenylate Kinase.

Bioinformatics Analysis of Non-Synonymous Single Nucleotide Polymorphisms in Human Adk Gene

Subtle Role for Adenylate Kinase 1 in Maintaining Normal Basal Contractile Function and Metabolism in the Murine Heart

Endogenous adenine is a potential driver of the cardiovascular-kidney-metabolic syndrome

Adenosine-Metabolizing Enzymes, Adenosine Kinase and Adenosine Deaminase, in Cancer

Studies on Factors Influencing Enzyme Responses to Adenylate Energy Charge

NUAK Kinases: Brain–Ovary Axis

Energetics and Structural Characterization of the large-scale Functional Motion of Adenylate Kinase

Adenosine Kinase Deficiency in the Brain Results in Maladaptive Synaptic Plasticity

Cellular Characterization of Adenylate Kinase and Its Isoform: Two-Photon Excitation Fluorescence Imaging and Fluorescence Correlation Spectroscopy.

Adenine nucleotide translocase: Current knowledge in post-translational modifications, regulations and pathological implications for human diseases

Human adenylate kinase 6 regulates WNK1 (with no lysine kinase-1) phosphorylation states and affects ion homeostasis in NT2 cells

The Mitochondrial NAD Kinase Functions As a Major Metabolic Regulator Upon Increased Energy Demand

Characterization of adenine nucleotide metabolism in the cellular model of Huntington's disease

Molecular mechanism of ATP versus GTP selectivity of adenylate kinase